Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders

Owing to their superior pharmacokinetic and pharmacodynamic profiles, potassium-competitive acid blockers (P-CABs) score over proton pump inhibitors (PPIs) in the treatment of gastric acid-related disorders and may provide clinical benefit in the management of these conditions. Previous studies have...

Full description

Saved in:
Bibliographic Details
Main Authors: Mun Young Cho, Yu Kyung Cho
Format: Article
Language:English
Published: Korean College of Helicobacter and Upper Gastrointestinal Research 2023-09-01
Series:The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Subjects:
Online Access:http://www.helicojournal.org/upload/pdf/kjhugr-2023-0043.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849248209782702080
author Mun Young Cho
Yu Kyung Cho
author_facet Mun Young Cho
Yu Kyung Cho
author_sort Mun Young Cho
collection DOAJ
description Owing to their superior pharmacokinetic and pharmacodynamic profiles, potassium-competitive acid blockers (P-CABs) score over proton pump inhibitors (PPIs) in the treatment of gastric acid-related disorders and may provide clinical benefit in the management of these conditions. Previous studies have compared P-CABs with PPIs for treatment of gastric acid-related disorders, and current data show that P-CABs are non-inferior to PPIs in the treatment of erosive esophagitis and as maintenance therapy. P-CABs are useful for effective healing and as maintenance medications in patients with severe esophagitis. These drugs also aid with healing of peptic ulcers and artificial ulcers secondary to gastric endoscopic submucosal dissection (ESD). Few studies have discussed prevention of delayed ulcer bleeding after gastric ESD and ulcers associated with long-term nonsteroidal anti-inflammatory drug administration. Well-controlled, large-scale prospective studies are warranted in future to compare P-CABs with PPIs.
format Article
id doaj-art-e5d8afb3bca54c2da599d0bb768c46ad
institution Kabale University
issn 1738-3331
language English
publishDate 2023-09-01
publisher Korean College of Helicobacter and Upper Gastrointestinal Research
record_format Article
series The Korean Journal of Helicobacter and Upper Gastrointestinal Research
spelling doaj-art-e5d8afb3bca54c2da599d0bb768c46ad2025-08-20T03:57:59ZengKorean College of Helicobacter and Upper Gastrointestinal ResearchThe Korean Journal of Helicobacter and Upper Gastrointestinal Research1738-33312023-09-0123316717310.7704/kjhugr.2023.0043789Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related DisordersMun Young Cho0Yu Kyung Cho1Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, KoreaDepartment of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, KoreaOwing to their superior pharmacokinetic and pharmacodynamic profiles, potassium-competitive acid blockers (P-CABs) score over proton pump inhibitors (PPIs) in the treatment of gastric acid-related disorders and may provide clinical benefit in the management of these conditions. Previous studies have compared P-CABs with PPIs for treatment of gastric acid-related disorders, and current data show that P-CABs are non-inferior to PPIs in the treatment of erosive esophagitis and as maintenance therapy. P-CABs are useful for effective healing and as maintenance medications in patients with severe esophagitis. These drugs also aid with healing of peptic ulcers and artificial ulcers secondary to gastric endoscopic submucosal dissection (ESD). Few studies have discussed prevention of delayed ulcer bleeding after gastric ESD and ulcers associated with long-term nonsteroidal anti-inflammatory drug administration. Well-controlled, large-scale prospective studies are warranted in future to compare P-CABs with PPIs.http://www.helicojournal.org/upload/pdf/kjhugr-2023-0043.pdfgastroesophageal refluxpeptic ulcerpotassium competitive acid blockerproton pump inhibitorstreatment
spellingShingle Mun Young Cho
Yu Kyung Cho
Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders
The Korean Journal of Helicobacter and Upper Gastrointestinal Research
gastroesophageal reflux
peptic ulcer
potassium competitive acid blocker
proton pump inhibitors
treatment
title Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders
title_full Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders
title_fullStr Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders
title_full_unstemmed Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders
title_short Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders
title_sort role of potassium competitive acid blockers in the treatment of gastric acid related disorders
topic gastroesophageal reflux
peptic ulcer
potassium competitive acid blocker
proton pump inhibitors
treatment
url http://www.helicojournal.org/upload/pdf/kjhugr-2023-0043.pdf
work_keys_str_mv AT munyoungcho roleofpotassiumcompetitiveacidblockersinthetreatmentofgastricacidrelateddisorders
AT yukyungcho roleofpotassiumcompetitiveacidblockersinthetreatmentofgastricacidrelateddisorders